Skip to main content
. 2021 Mar 9;38(4):254–261. doi: 10.1177/1043454221992321

Table 1.

Descriptive Summary of Sample Demographic and Clinical Characteristics (N = 128).

Characteristic Mean (SD)
Age 10.9 (3.0)
N (%)
Child sex
 Male 60 (46.9%)
 Female 68 (53.1%)
Race (N = 126)
 White 107 (84.9%)
 Black or African American 4 (3.2%)
 Asian 2 (1.6%)
 American Indian or Alaska Native 2 (1.6%)
 Other 11 (8.7%)
Ethnicity (N = 126)
 Hispanic or Latino 15 (11.9%)
 Not Hispanic or Latino 111 (88.1%)
Primary language
 English 124 (96.9%)
 Spanish 4 (3.1%)
Location of permanent home
 Northeast 17 (13.3%)
 Southeast 29 (22.7%)
 Midwest 66 (51.6%)
 Southwest 11 (8.6%)
 West 5 (3.9%)
Current family income per year
 Under $25,000 50 (39.1%)
 $25,001–$50,000 31 (24.2%)
 $50,001–$75,000 16 (12.5%)
 $75,001–$100,000 15 (11.7%)
 $100,001 or more 16 (12.5%)
Malignancy type
 Hematologic 67 (52.3%)
 Solid tumor 34 (26.6%)
 CNS tumor 27 (21.1%)
History of:
 Cancer relapse or recurrence 88 (68.8%)
 Secondary cancer (N = 127) 3 (2.4%)
 Surgery to remove a tumor 53 (41.4%)
 Chemotherapy treatments 121 (94.5%)
 Radiation therapy 85 (66.4%)
 Bone marrow transplant 22 (17.3%)
Phase 1 clinical research involvement
 Yes 22 (17.2%)
 No 78 (60.9%)
 Unsure 28 (21.9%)
Been told cancer is terminal 13 (10.2%)
Presence of active DNR order 2 (1.6%)
Currently enrolled in hospice
 Yes 2 (1.6%)
 No 125 (97.7%)
 Unknown 1 (0.8%)
Currently enrolled in palliative care
 Yes 7 (5.5%)
 No 115 (89.8%)
 Unknown 6 (4.7%)
Median (IQR)
Years since diagnosis (N = 127) 3.9 (1.8, 6.0)

Note. DNR: Do not resuscitate.